Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Ranolazine in Heart Failure Patients with Preserved Ejection Fraction
2011-000805-27Phase 2Completed
- Sponsor
- Menarini Group
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in heart failure with preserved ejection fraction (HFpEF) comparing Ranolazine with Placebo (2 arms). Primary endpoint: 6-minute walk test distance. Started Apr 2012; status: completed.
02
Drugs
ranolazine
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on 2011-000805-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000805-27.